Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Urschitz Martina |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Pieber, TR; Arfelt, KN; Cailleteau, R; Thomsen, KMD; Hart, M; Mursic, I; Svehlikova, E; Urschitz, M; Haahr, H
Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin icodec versus once-daily insulin glargine in type 2 diabetes
DIABETOLOGIA. 2022; 65(SUPPL 1):S333-S333.-58th Annual Meeting of the European Association for the Study of Diabetes; Sep 20-23, 2022; Stockholm.
[Oral Communication]
Web of Science
Svehlikova, E; Hoeller, V; Urschitz, M; Wolf, M; Lackner, B; Magnes, C; Ratzer, M; Gerring, D; Jezek, J; Howell, SJ; Zakrzewski, L; Pillai, V; Ashcroft, N; Lawrence, F; Pieber, TR
Phase I study investigating PK and PD of highly concentrated insulin aspart AT278 U500
DIABETOLOGIA. 2022; 65(SUPPL 1):S209-S210.-58th EASD Annual Meeting; Sep 19-23, 2022; Stockholm, Sweden.
[Poster]
Web of Science
Svehlikova, E; Holler, V; Gumilar, J; Fluhr, G; Urschitz, M; Wolf, M; Lackner, B; Magnes, C; Ratzer, M; Gerring, DJ; Jezek, J; Howell, SJ; Zakrzewski, L; Pillai, V; Ashcroft, N; Lawrence, FJ; Pieber, TR
Phase I study investigating PK and -PD of highly-concentrated insulin aspart AT278 U500
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):262-262.
[Oral Communication]
Web of Science
Svehlikova, E; Holler, V; Urschitz, M; Wolf, M; Lackner, B; Magnes, C; Ratzer, M; Gerring, D; Jezek, J; Howell, S; Zakrzewski, L; Pillai, V; Ashcroft, N; Lawrence, F; Pieber, T
AT278 (U500) - PK/PD AND SAFETY OF RAPID-ACTING CONCENTRATED INSULIN ASPART
DIABETES TECHNOL THE. 2022; 24: A39-A40.-ATTD 2022 ; APR 27-30, 2022; Barcelona, Spain.
[Oral Communication]
Web of Science
Mursic, I; Svehlikova, E; Regittnig, W; Augustin, T; Magnes, C; Eberl, A; Heise, T; Klein, O; Wolf, M; Urschitz, M; Brunner, M; Sourij, H; Pieber, T
Acid–Base Changes during Diabetic Ketoacidosis (DKA) in T1DM with and without SGLT2 Inhibitor (SGLT2i).
Diabetes 2020 Jun; 69(Supplement 1): 25-OR. 2020; 69(Suppl ):25-OR--80th ADA Scientific Session; JUN 12-16, 2020; Chicago, USA.
[Oral Communication]
FullText
Mursic, I; Svehlikova, E; Regittnig, W; Urschitz, M; Wolf, M; Brunner, M; Augustin, T; Magnes, C; Eberl, A; Heise, T; Klein, O; Sourij, H; Pieber, T
Acid-base changes during diabetic ketoacidosis in type 1 diabetes with/without SGLT2 inhibitor.
DIABETOLOGIA. 2020; 63(SUPPL 1):S272-S273.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK.
[Oral Communication]
Web of Science
Svehlikova, E; Merle,D; Sourij, H; Narath, S; Augustin, T; Magnes, C; Eberl, A; Urschitz, M; Wolf, M; Regittnig, W; Pieber, T
A Novel Insulin Depletion Protocol Combined with Stable Tracer Approach Assessing Intermediate Metabolism Can Be Efficiently Used for Investigation of the Development of Diabetic Ketoacidosis
The 3rd World Congress on Clinical Trials in Diabetes; DEC 3-4, 2018; Vienna, AUSTRIA. 2018.
[Poster]
Svehlikova, E; Sach-Friedl, S; Schadler, H-P; Augustin, T; Magnes, C; Eberl, A; Narath, S; Urschitz, M; Wolf, M; Treiber, G; Pieber, T
A Novel Stepwise eu-, Hyper-, and Hypoglycaemic Clamp Using Stable Tracer Method for Comparison of Glucose Fluxes and Lipolysis in Type 1 and Type 2 Diabetes Mellitus
3rd Wolrd Congress on Clinical Trials in Diabetes; DEC 3-4, 2018; Vienna, AUSTRIA. 2018.
[Poster]
Svehlikova, E; Sach-Friedl, S; Schadler, HP; Augustin, T; Magnes, C; Eberl, A; Narath, S; Urschitz, M; Wolf, M; Treiber, G; Pieber, TR
A novel stepwise eu-, hyper- and hypoglycaemic clamp using stable tracer method to compare glucose fluxes and lipolysis in type 1 and type 2 diabetes
DIABETOLOGIA. 2017; 60: S115-S116.-53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL.
[Oral Communication]
Web of Science
Zenz, S; Regittnig, W; Urschitz, M; Brunner, M; Korsatko, S; Raml, R; Narath, S; Magnes, C; Tschapeller, B; Augustin, T, Pieber, TR
Endogenous Glucose Production during Hypoglycemia in Patients with Newly Diagnosed and Long-Standing Type 1 Diabetes.
Diabetes. 2015; 64(S1):A506-A506.-75th Scientific Sessions of the American Diabetes Association (ADA); JUN 5-9, 2015; Boston, USA.
[Poster]
Zenz, S; Regittnig, W; Urschitz, M; Brunner, M; Korsatko, S; Raml, R; Narath, S; Magnes, C; Tschapeller, B; Augustin, T; Pieber, TR
Endogenous Glucose Production during an induced Hypoglycemia in newly diagnosed and long term Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2015; 127: S136-S136.
[Oral Communication]
Web of Science
Brunner, M.; Korsatko, S.; Deller, S.; Kojzar H.; Wolf M.; Urschitz M.; Roepstorff C.; Svendsen A.L.; Haahr H.; Pieber T.R.
Prandiale und basale pharmakodynamische Eigenschaften von Insulin IDegAsp bei jungen und älteren Probandnnen mit Typ 1 Diabetes sind vergleichbar.
Wiener Klinische Wochenschrift. 2013; 125(21-22):19-19.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 21 - 23, 2013; Salzburg, AUSTRIA.
[Poster]
Kojzar, H; Urschitz, M; Lehki, B; Mader, JK; Ehrmann, M; Ellmerer, M; Pieber, TR; Regittnig, W; im Namen des AP@home-Konsortiums
Subkutane Bolusgabe mit Insulinpumpe bei Typ-1-Diabetikern Auswirkung der Boluslänge auf die Absorptionskinetik von schnell wirksamem Insulin.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S14-S15.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA.
[Oral Communication]
Regittnig, W; Urschitz, M; Lehki, B; Mader, J; Ehrmann, M; Kojzar, H; Ellmerer, M; Pieber, TR
Absorption Kinetics of Insulin Following Subcutaneous Bolus Administration With Different Bolus Duration.
Diabetes. 2013; 62(S11):A247-A247.-73rd Scientific Sessions of the American Diabetes Association (ADA); JUN 21-25, 2013; Chicago, USA.
[Poster]
Urschitz M.; Korsatko S.; Deller S.; Gurban J.; Wolf M.; Brunner M.; Heller S.R.; Jensen L.; Kiyom F.; Christiansen E.; Pieber T.R.
Liraglutide in Kombination mit Insulin bei Typ-1-Diabetes: glykämischer Effekt und Sicherheit in einer randomisierten, doppelblinden Crossover-Studie.
Wiener Klinische Wochenschrift. 2013; 125(21-22):14-14.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 21-23, 2013; Salzburg, AUSTRIA.
[Oral Communication]
Korsatko, S; Deller, S; Mader, J; Glettler, K; Köhler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup, H; Sondergaard, F; Haahr, H; Pieber, TR.
Ultralange, pharmakokinetische und pharmakodynamische Eigenschaften von Insulin Degludec bei jungen und älteren ProbandInnen mit Typ 1 Diabetes sind vergleichbar.
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):8-9.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA.
[Oral Communication]
Korsatko, S; Deller, S; Mader, J; Glettler, K; Köhler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup-Nielsen, H; Søndergaard, F; Haahr, HL; Pieber, TR
Ultra-long pharmacokinetic properties of insulin degludec in younger adults are preserved in geriatric subjects with type 1 diabetes.
Diabetologia. 2012; 55(S1):379-380.-48th Annual Meeting of the European Association for the Study of Diabetes (EASD); OCT 1-5, 2012; Berlin, GERMANY.
[Poster]
Korsatko, S; Deller, S; Mader, JK; Glettler, K; Koehler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup, H; Sondergaard, F; Haahr, HL; Pieber, TR.
Ultra-long pharmacokinetic properties of insulin degludec in younger adults preserved in geriatric subjects with T1DM.
Konferenzband. 2012; -9th IDF-WPR (International Diabetes Federation West Pacific Region) Congress & 4th AASD Scientific Meeting; NOV 24-27, 2012; Kyoto, JAPAN.
[Poster]
Korsato, S; Deller, S; Mader, J; Glettler, K; Köhler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup-Nieslen, H; Sondergaard, F; Haahr, H; Pieber, T.
Ultra-long pharmacokinetic properties of insulin degludec in younger adults are preserved in geriatric subjects with type 1 diabetes
Poster & Oral Presentation Guide and Abstract Book. 2012; A259-A259.-American Association of Clinical Endocrinologists 21st Annual Scientific and Clinical Congress; MAY 23-27, 2012; Philadelphia, USA.
[Oral Communication]
Deller, S; Neubauer, K; Korsatko, S; Wolf, M; Urschitz, M; Zahiragic, S; Mader, J; Adrian, C; Thomsen, H; Haahr, H; Pieber, T
Ultra-Long-acting insulin Degludec: Two different concentrations (U100 and U200) showing bioequivalence and comparable pharmacodynamics
WIEN KLIN WOCHENSCHR. . 2011; 123: S10-S11.-39. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2011; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Mader, J; Lucarelli, F; Scuffi, C; Friedrich, S; Korsatko, S; Urschitz, M; Wolf, M; Ellmerer, M; Valgimigli, F; Pieber, T
Evaluate the safety and accuracy of GlucoMen (R) Day system for continuous subcutaneous glucose monitoring in patients with Type 1 diabetes
WIEN KLIN WOCHENSCHR. . 2011; 123: S5-S5.-39. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2011; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Bock, G; Mader, J; Prietl, B; Fruhmann, J; Urschitz, M; Hueter, N; Obermayer-Pietsch, B; Pieber, T
Placebo-controlled trial to investigate dan effects of vitamin D substitution on the glucose metabolism in healthy subjects.
WIEN KLIN WOCHENSCHR. 2010; 122: S5-S5.-ÖDG;
[Oral Communication]
Web of Science